In recent years, several studies have proved that TSTA3 was overexpressed, and involved in malignant progression and poor prognosis in gastric cancer, breast cancer and other cancers, which is involved in tumorigenesis and progression of tumors, and thus affecting the prognosis of patients [13–17]. This evidence concerns the gene GFUS and breast carcinoma.